Loading…
Cardiac Syndrome X: Advances in Treatment for Chest Pain without Artery Stenosis
The number of patients diagnosed with Cardiac Syndrome X continues to increase. This condition is marked by anginal pain despite the absence of abnormal findings on coronary angiography or coronary spasm. It is considered a form of ischemic heart disease, with its incidence being most common among w...
Saved in:
Published in: | Journal of education, health and sport health and sport, 2024-12, Vol.76, p.56434 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | |
container_start_page | 56434 |
container_title | Journal of education, health and sport |
container_volume | 76 |
creator | Tulej, Dawid Furtak, Daria Dziedzic, Alicja Niewiadomska, Jagoda Marko, Natalia Grela, Wiktor Głogowska, Paulina Marciniuk, Dominika Górska, Aleksandra Gniaź, Natalia |
description | The number of patients diagnosed with Cardiac Syndrome X continues to increase. This condition is marked by anginal pain despite the absence of abnormal findings on coronary angiography or coronary spasm. It is considered a form of ischemic heart disease, with its incidence being most common among women in the perimenopausal and postmenopausal stages. The aim of this article is to review therapeutic options for Cardiac Syndrome X. The most effective treatments commonly used include calcium channel blockers and beta-blockers, including newer generation options that promote vasodilation in the endothelium. Angiotensin-converting enzyme (ACE) inhibitors are also frequently used to enhance therapeutic outcomes. Other medications used were nitrates, statins, ranolazine, imipramine, nicorandil, aminophylline, cilostazol, sildenafil, fasudil. Emerging theories suggest altered pain perception, potentially involving heightened neural sensitivity, may significantly contribute to the symptoms in CSX. Additionally, studies indicate that vitamin D supplementation, often beneficial for cardiovascular health, may alleviate symptoms in CSX. Non-pharmacological methods also have proven efficacy, such as Enhanced External Counterpulsation, spinal cord stimulation and transcutaneous electrical nerve stimulation. Lifestyle changes and (CBT) also play a crucial role in the comprehensive management of Cardiac Syndrome X (CSX), targeting factors that pharmacological treatments alone may not address. |
doi_str_mv | 10.12775/JEHS.2024.76.56434 |
format | article |
fullrecord | <record><control><sourceid>doaj_cross</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_040413007c4440888e8922302826e3e1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_040413007c4440888e8922302826e3e1</doaj_id><sourcerecordid>oai_doaj_org_article_040413007c4440888e8922302826e3e1</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1101-dad73975681c69e82201696e5b8e2d1401b5fdb5d92128de9bfc199c45786df13</originalsourceid><addsrcrecordid>eNpNkN1KAzEQhRdRsNQ-gTd5ga2Z_G3iXVmqrRQstIJ3IZvM2i3triSr0re3rSJezWEOfBy-LLsFOgZWFPLuaTpbjRllYlyosVSCi4tswLiBXHOqLv_l62yU0pZSCkoCSDrIlqWLoXGerA5tiN0eyes9mYRP13pMpGnJOqLr99j2pO4iKTeYerJ0x-Kr6TfdR08mscd4IKse2y416Sa7qt0u4ej3DrOXh-m6nOWL58d5OVnkHoBCHlwouCmk0uCVQc3YcZNRKCuNLICgUMk6VDIYBkwHNFXtwRgvZKFVqIEPs_kPN3Rua99js3fxYDvX2POji2_Wxb7xO7RUUAGc0sILIajWGrVhjFOmmUKOJxb_YfnYpRSx_uMBtWfH9uTYnhzbQtmzY_4NACtsog</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cardiac Syndrome X: Advances in Treatment for Chest Pain without Artery Stenosis</title><source>DOAJ Directory of Open Access Journals</source><creator>Tulej, Dawid ; Furtak, Daria ; Dziedzic, Alicja ; Niewiadomska, Jagoda ; Marko, Natalia ; Grela, Wiktor ; Głogowska, Paulina ; Marciniuk, Dominika ; Górska, Aleksandra ; Gniaź, Natalia</creator><creatorcontrib>Tulej, Dawid ; Furtak, Daria ; Dziedzic, Alicja ; Niewiadomska, Jagoda ; Marko, Natalia ; Grela, Wiktor ; Głogowska, Paulina ; Marciniuk, Dominika ; Górska, Aleksandra ; Gniaź, Natalia</creatorcontrib><description>The number of patients diagnosed with Cardiac Syndrome X continues to increase. This condition is marked by anginal pain despite the absence of abnormal findings on coronary angiography or coronary spasm. It is considered a form of ischemic heart disease, with its incidence being most common among women in the perimenopausal and postmenopausal stages. The aim of this article is to review therapeutic options for Cardiac Syndrome X. The most effective treatments commonly used include calcium channel blockers and beta-blockers, including newer generation options that promote vasodilation in the endothelium. Angiotensin-converting enzyme (ACE) inhibitors are also frequently used to enhance therapeutic outcomes. Other medications used were nitrates, statins, ranolazine, imipramine, nicorandil, aminophylline, cilostazol, sildenafil, fasudil. Emerging theories suggest altered pain perception, potentially involving heightened neural sensitivity, may significantly contribute to the symptoms in CSX. Additionally, studies indicate that vitamin D supplementation, often beneficial for cardiovascular health, may alleviate symptoms in CSX. Non-pharmacological methods also have proven efficacy, such as Enhanced External Counterpulsation, spinal cord stimulation and transcutaneous electrical nerve stimulation. Lifestyle changes and (CBT) also play a crucial role in the comprehensive management of Cardiac Syndrome X (CSX), targeting factors that pharmacological treatments alone may not address.</description><identifier>ISSN: 2391-8306</identifier><identifier>EISSN: 2391-8306</identifier><identifier>DOI: 10.12775/JEHS.2024.76.56434</identifier><language>eng</language><publisher>Kazimierz Wielki University</publisher><subject>cardiac syndrome X ; ischemic heart disease ; microvascular angina ; pharmacological therapy</subject><ispartof>Journal of education, health and sport, 2024-12, Vol.76, p.56434</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0009-0003-2219-984X ; 0009-0008-3329-9770 ; 0000-0003-0768-9800 ; 0009-0000-0710-8485 ; 0009-0004-0141-2821 ; 0009-0002-3003-4466 ; 0000-0002-5711-3423 ; 0009-0004-7815-4592 ; 0009-0001-0460-4106 ; 0009-0000-5801-5756</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,2101,27923,27924</link.rule.ids></links><search><creatorcontrib>Tulej, Dawid</creatorcontrib><creatorcontrib>Furtak, Daria</creatorcontrib><creatorcontrib>Dziedzic, Alicja</creatorcontrib><creatorcontrib>Niewiadomska, Jagoda</creatorcontrib><creatorcontrib>Marko, Natalia</creatorcontrib><creatorcontrib>Grela, Wiktor</creatorcontrib><creatorcontrib>Głogowska, Paulina</creatorcontrib><creatorcontrib>Marciniuk, Dominika</creatorcontrib><creatorcontrib>Górska, Aleksandra</creatorcontrib><creatorcontrib>Gniaź, Natalia</creatorcontrib><title>Cardiac Syndrome X: Advances in Treatment for Chest Pain without Artery Stenosis</title><title>Journal of education, health and sport</title><description>The number of patients diagnosed with Cardiac Syndrome X continues to increase. This condition is marked by anginal pain despite the absence of abnormal findings on coronary angiography or coronary spasm. It is considered a form of ischemic heart disease, with its incidence being most common among women in the perimenopausal and postmenopausal stages. The aim of this article is to review therapeutic options for Cardiac Syndrome X. The most effective treatments commonly used include calcium channel blockers and beta-blockers, including newer generation options that promote vasodilation in the endothelium. Angiotensin-converting enzyme (ACE) inhibitors are also frequently used to enhance therapeutic outcomes. Other medications used were nitrates, statins, ranolazine, imipramine, nicorandil, aminophylline, cilostazol, sildenafil, fasudil. Emerging theories suggest altered pain perception, potentially involving heightened neural sensitivity, may significantly contribute to the symptoms in CSX. Additionally, studies indicate that vitamin D supplementation, often beneficial for cardiovascular health, may alleviate symptoms in CSX. Non-pharmacological methods also have proven efficacy, such as Enhanced External Counterpulsation, spinal cord stimulation and transcutaneous electrical nerve stimulation. Lifestyle changes and (CBT) also play a crucial role in the comprehensive management of Cardiac Syndrome X (CSX), targeting factors that pharmacological treatments alone may not address.</description><subject>cardiac syndrome X</subject><subject>ischemic heart disease</subject><subject>microvascular angina</subject><subject>pharmacological therapy</subject><issn>2391-8306</issn><issn>2391-8306</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpNkN1KAzEQhRdRsNQ-gTd5ga2Z_G3iXVmqrRQstIJ3IZvM2i3triSr0re3rSJezWEOfBy-LLsFOgZWFPLuaTpbjRllYlyosVSCi4tswLiBXHOqLv_l62yU0pZSCkoCSDrIlqWLoXGerA5tiN0eyes9mYRP13pMpGnJOqLr99j2pO4iKTeYerJ0x-Kr6TfdR08mscd4IKse2y416Sa7qt0u4ej3DrOXh-m6nOWL58d5OVnkHoBCHlwouCmk0uCVQc3YcZNRKCuNLICgUMk6VDIYBkwHNFXtwRgvZKFVqIEPs_kPN3Rua99js3fxYDvX2POji2_Wxb7xO7RUUAGc0sILIajWGrVhjFOmmUKOJxb_YfnYpRSx_uMBtWfH9uTYnhzbQtmzY_4NACtsog</recordid><startdate>20241221</startdate><enddate>20241221</enddate><creator>Tulej, Dawid</creator><creator>Furtak, Daria</creator><creator>Dziedzic, Alicja</creator><creator>Niewiadomska, Jagoda</creator><creator>Marko, Natalia</creator><creator>Grela, Wiktor</creator><creator>Głogowska, Paulina</creator><creator>Marciniuk, Dominika</creator><creator>Górska, Aleksandra</creator><creator>Gniaź, Natalia</creator><general>Kazimierz Wielki University</general><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope><orcidid>https://orcid.org/0009-0003-2219-984X</orcidid><orcidid>https://orcid.org/0009-0008-3329-9770</orcidid><orcidid>https://orcid.org/0000-0003-0768-9800</orcidid><orcidid>https://orcid.org/0009-0000-0710-8485</orcidid><orcidid>https://orcid.org/0009-0004-0141-2821</orcidid><orcidid>https://orcid.org/0009-0002-3003-4466</orcidid><orcidid>https://orcid.org/0000-0002-5711-3423</orcidid><orcidid>https://orcid.org/0009-0004-7815-4592</orcidid><orcidid>https://orcid.org/0009-0001-0460-4106</orcidid><orcidid>https://orcid.org/0009-0000-5801-5756</orcidid></search><sort><creationdate>20241221</creationdate><title>Cardiac Syndrome X: Advances in Treatment for Chest Pain without Artery Stenosis</title><author>Tulej, Dawid ; Furtak, Daria ; Dziedzic, Alicja ; Niewiadomska, Jagoda ; Marko, Natalia ; Grela, Wiktor ; Głogowska, Paulina ; Marciniuk, Dominika ; Górska, Aleksandra ; Gniaź, Natalia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1101-dad73975681c69e82201696e5b8e2d1401b5fdb5d92128de9bfc199c45786df13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>cardiac syndrome X</topic><topic>ischemic heart disease</topic><topic>microvascular angina</topic><topic>pharmacological therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tulej, Dawid</creatorcontrib><creatorcontrib>Furtak, Daria</creatorcontrib><creatorcontrib>Dziedzic, Alicja</creatorcontrib><creatorcontrib>Niewiadomska, Jagoda</creatorcontrib><creatorcontrib>Marko, Natalia</creatorcontrib><creatorcontrib>Grela, Wiktor</creatorcontrib><creatorcontrib>Głogowska, Paulina</creatorcontrib><creatorcontrib>Marciniuk, Dominika</creatorcontrib><creatorcontrib>Górska, Aleksandra</creatorcontrib><creatorcontrib>Gniaź, Natalia</creatorcontrib><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of education, health and sport</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tulej, Dawid</au><au>Furtak, Daria</au><au>Dziedzic, Alicja</au><au>Niewiadomska, Jagoda</au><au>Marko, Natalia</au><au>Grela, Wiktor</au><au>Głogowska, Paulina</au><au>Marciniuk, Dominika</au><au>Górska, Aleksandra</au><au>Gniaź, Natalia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiac Syndrome X: Advances in Treatment for Chest Pain without Artery Stenosis</atitle><jtitle>Journal of education, health and sport</jtitle><date>2024-12-21</date><risdate>2024</risdate><volume>76</volume><spage>56434</spage><pages>56434-</pages><issn>2391-8306</issn><eissn>2391-8306</eissn><abstract>The number of patients diagnosed with Cardiac Syndrome X continues to increase. This condition is marked by anginal pain despite the absence of abnormal findings on coronary angiography or coronary spasm. It is considered a form of ischemic heart disease, with its incidence being most common among women in the perimenopausal and postmenopausal stages. The aim of this article is to review therapeutic options for Cardiac Syndrome X. The most effective treatments commonly used include calcium channel blockers and beta-blockers, including newer generation options that promote vasodilation in the endothelium. Angiotensin-converting enzyme (ACE) inhibitors are also frequently used to enhance therapeutic outcomes. Other medications used were nitrates, statins, ranolazine, imipramine, nicorandil, aminophylline, cilostazol, sildenafil, fasudil. Emerging theories suggest altered pain perception, potentially involving heightened neural sensitivity, may significantly contribute to the symptoms in CSX. Additionally, studies indicate that vitamin D supplementation, often beneficial for cardiovascular health, may alleviate symptoms in CSX. Non-pharmacological methods also have proven efficacy, such as Enhanced External Counterpulsation, spinal cord stimulation and transcutaneous electrical nerve stimulation. Lifestyle changes and (CBT) also play a crucial role in the comprehensive management of Cardiac Syndrome X (CSX), targeting factors that pharmacological treatments alone may not address.</abstract><pub>Kazimierz Wielki University</pub><doi>10.12775/JEHS.2024.76.56434</doi><orcidid>https://orcid.org/0009-0003-2219-984X</orcidid><orcidid>https://orcid.org/0009-0008-3329-9770</orcidid><orcidid>https://orcid.org/0000-0003-0768-9800</orcidid><orcidid>https://orcid.org/0009-0000-0710-8485</orcidid><orcidid>https://orcid.org/0009-0004-0141-2821</orcidid><orcidid>https://orcid.org/0009-0002-3003-4466</orcidid><orcidid>https://orcid.org/0000-0002-5711-3423</orcidid><orcidid>https://orcid.org/0009-0004-7815-4592</orcidid><orcidid>https://orcid.org/0009-0001-0460-4106</orcidid><orcidid>https://orcid.org/0009-0000-5801-5756</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2391-8306 |
ispartof | Journal of education, health and sport, 2024-12, Vol.76, p.56434 |
issn | 2391-8306 2391-8306 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_040413007c4440888e8922302826e3e1 |
source | DOAJ Directory of Open Access Journals |
subjects | cardiac syndrome X ischemic heart disease microvascular angina pharmacological therapy |
title | Cardiac Syndrome X: Advances in Treatment for Chest Pain without Artery Stenosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiac%20Syndrome%20X:%20Advances%20in%20Treatment%20for%20Chest%20Pain%20without%20Artery%20Stenosis&rft.jtitle=Journal%20of%20education,%20health%20and%20sport&rft.au=Tulej,%20Dawid&rft.date=2024-12-21&rft.volume=76&rft.spage=56434&rft.pages=56434-&rft.issn=2391-8306&rft.eissn=2391-8306&rft_id=info:doi/10.12775/JEHS.2024.76.56434&rft_dat=%3Cdoaj_cross%3Eoai_doaj_org_article_040413007c4440888e8922302826e3e1%3C/doaj_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1101-dad73975681c69e82201696e5b8e2d1401b5fdb5d92128de9bfc199c45786df13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |